Clinical Trials Browser

Phase 4 × ixazomib × Plasma cell × Clear all

NCT05722405 2026-01-05

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Phase 4 Recruiting

Multiple Myeloma

NCT04217967 2024-08-01

Ixazomib, Lenalidomide, and Combination for Maintenance in NDMM Patients

Phase 4 Completed

Multiple Myeloma

NCT05183139 2022-05-03

US MM-7

Phase 4 Withdrawn

Multiple Myeloma